Chih Hung Lo, Ph.D.
Team Leader
Chih Hung obtained his Ph.D. from University of Minnesota where he investigated the molecular mechanisms of inflammation (TNF receptor signaling) and neurodegeneration (IDP aggregation). He also performed small molecule drug discovery by combining fluorescent biosensor engineering, FRET high-throughput screening, and medicinal chemistry. He went on to do a postdoctoral training at Brigham and Women's Hospital/Harvard Medical School where he used mouse genetics to study age-dependent neurodegeneration in Alzheimer's disease (AD). Before joining NTU, Chih Hung received another postdoctoral training at Yale School of Medicine where he focused on using highly multiplexed immunofluorescence imaging for single-cell spatial analysis to study multiple sclerosis (MS) pathology and applying iPSC technology to investigate the contribution of glial cells to MS pathogenesis. Chih Hung's research interest focuses on neuroinflammation and neurodegeneration, specifically related to the role of TNF receptors in AD and MS.